MAPT and Alzheimer disease: Tau-PET will still be very meaningful in these individuals, and will not just confirm tau positivity, but also give relevant information on topographical tau distribution, which is clinically useful per se and can also be used to identify different AD subtypes with different clinical phenotypes and prognosis5.